Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
SSM Popul Health ; 27: 101691, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38988726

ABSTRACT

Mental health has deteriorated globally due to COVID-19, climate crisis, economic policies, and regional conflicts, requiring immediate attention. This study aims to comprehend the relationship between economic uncertainty and the prevalence of anxiety disorders, major depressive disorder, and eating disorders across various demographics and countries. Using robust fixed-effect models, we analyzed the relationship between economic uncertainty and mental disorders in 110 countries from 1991 to 2019. Our analysis also explored whether this association varies across genders and age groups. Our analysis indicates that economic uncertainty is associated with higher prevalence rates of anxiety and major depressive disorders, though no similar association is observed for eating disorders. In the subgroup analyses, while females have a significant association exclusively with anxiety disorders, males have associations with anxiety and major depressive disorders. The age-specific analyses show that economic uncertainty is associated with anxiety disorders for almost all age groups above 15 years, except for ages between 40 and 54. For major depressive disorders, this association becomes significant after the 40-44 age group. However, we see no significant association among age groups for eating disorders.

2.
Sci Data ; 9(1): 441, 2022 07 23.
Article in English | MEDLINE | ID: mdl-35871225

ABSTRACT

This data was gathered to investigate how individuals' levels of intolerance to distress and instant anxiety are related to some of the behaviors that people can change in response to the COVID-19 pandemic. We present a dataset based on a four-wave survey of the social and psychological effects of the COVID-19 pandemic in Turkey (N = 2,817). Turkey was heavily impacted by the first waves of infections in 2020, and citizens were forced to adapt to governmental measures. So, the dataset provides unique opportunities to investigate the COVID-19 pandemic's role in shaping people's intolerance to distress and instant anxiety. The survey considered personal cleaning behavior, bank/credit card usage, online spending habits, individual security perception, and stockpile behavior. Furthermore, in this data, whether an individual or a household member was officially diagnosed with COVID-19 and socio-demographic indicators were determined. Hence, the resulting dataset can enable various analyses on social, psychological, perceived security, and self-rated health, influencing how individuals' levels of intolerance to distress and instant anxiety.


Subject(s)
COVID-19 , SARS-CoV-2 , Anxiety/epidemiology , COVID-19/epidemiology , COVID-19/psychology , Humans , Pandemics , Turkey/epidemiology
3.
J Surg Res ; 243: 165-172, 2019 11.
Article in English | MEDLINE | ID: mdl-31177036

ABSTRACT

BACKGROUND: 1,25 Dihydroxyvitamin D3 (1,25(OH)2D3) modulates inflammation and immune responses. Deficiency of 1,25(OH)2D3 was found to be associated with the risk of cancer, cardiovascular disease, osteoarthritis, infections, and autoimmune diseases. This study evaluated the effect of 1,25 dihydroxyvitamin D3 1,25(OH)2D3 on thioacetamide (TAA)-induced acute liver injury in rats. MATERIALS AND METHODS: Rats were treated with either saline or 1,25(OH)2D3 (0.30 µg/kg; orogastrically) for 15 d. Starting from day 13, TAA (200 mg/kg; intraperitoneally) was given for 3 d. On day 15, all rats were euthanized. Liver and blood samples were collected. RESULTS: TAA caused severe damage, increased lipid peroxidation with reductions in endogenous antioxidants, increased apoptosis, increased production of reactive oxygen species, and elevated inducible nitric oxide synthase (iNOS), and nuclear factor kappa B (NF-κB) expression in liver. Extent of damage was decreased by 1,25(OH)2D3 (P < 0.01). 1,25(OH)2D3 attenuated the increase in malondialdehyde (P < 0.01), increase in myeloperoxidase (P < 0.01), increase in chemiluminescence levels (P < 0.05) and apoptotic activity (P < 0.001). Elevated liver iNOS and NF-κB expression in TAA group was also reduced by 1,25(OH)2D3 (P < 0.001, for iNOS; P < 0.001, for NF-κB). TAA group revealed high serum aspartate transaminase and alanine transaminase (ALT) activities (P < 0.01, for aspartate transaminase; P = 0.08, for ALT) and reduced albumin levels (P < 0.01) compared with control. 1,25(OH)2D3 had no statistically significant effect on these parameters. CONCLUSIONS: 1,25(OH)2D3 provides protection against hepatic injury in a rat model of TAA-induced hepatotoxicity via suppression of inflammatory reaction, oxidative stress, and apoptosis.


Subject(s)
Calcitriol/therapeutic use , Chemical and Drug Induced Liver Injury/prevention & control , Drug Evaluation, Preclinical , Animals , Apoptosis/drug effects , Calcitriol/pharmacology , Chemical and Drug Induced Liver Injury/pathology , Female , Liver/drug effects , Liver/enzymology , Liver/pathology , Random Allocation , Rats, Sprague-Dawley , Thioacetamide
SELECTION OF CITATIONS
SEARCH DETAIL
...